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Transactive response DNA-binding protein 43 (TDP-43) mislocalization and aggregation are hallmark features of amyotrophic lateral
sclerosis and frontotemporal dementia (FTD). We have previously shown in mice that inducible overexpression of a cytoplasmically
localized form of TDP-43 (TDP-43-NLS) in forebrain neurons evokes neuropathological changes that recapitulate several features of
TDP-43proteinopathies.Detailedbehavioral phenotyping couldprovide further validation for itsusageas amodel forFTD. In thepresent
study, we performed a battery of behavioral tests to evaluate motor, cognitive, and social phenotypes in this model. We found that
transgene (Tg) inductionbydoxycycline removal atweaning led tomotor abnormalities includinghyperlocomotion in theopen field test,
impaired coordination and balance in the rotarod test, and increased spasticity as shown by a clasping phenotype. Cognitive assessment
demonstrated impaired recognition and spatial memory, measured by novel object recognition and Y-maze tests. Remarkably, TDP-43-
NLSmice displayed deficits in social behavior, mimicking a key aspect of FTD. To determine whether these symptoms were reversible,
we suppressed Tg expression for 14 d in 1.5-month-old mice showing an established behavioral phenotype but modest neurodegenera-
tion and found that motor and cognitive deficits were ameliorated; however, social performance remained altered. When Tg expression
was suppressed in 6.5-month-old mice showing overt neurodegeneration, motor deficits were irreversible. These results indicate that
TDP-43-NLS mice display several core behavioral features of FTD with motor neuron disease, possibly due to functional changes in
surviving neurons, and might serve as a valuable tool to unveil the underlying mechanisms of this and other TDP-43 proteinopathies.
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Introduction
Neurodegenerative diseases characterized by neuronal and glial
inclusions mainly composed of insoluble transactive response
DNA-binding protein 43 (TDP-43) are now collectively referred
to as TDP-43 proteinopathies. Frontotemporal lobar degenera-
tion with ubiquitinated TDP-43 inclusions (FTLD-TDP) and
amyotrophic lateral sclerosis (ALS) are the most prevalent
TDP-43 proteinopathies (Neumann et al., 2006). In the past few
years, the identification of mutations in TARDBP (the gene en-
coding TDP-43) that are linked to both sporadic and familial ALS
indicated that alteration of TDP-43 can cause neurodegeneration
directly (Gitcho et al., 2008; Kabashi et al., 2008; Rutherford et al.,
2008; Sreedharan et al., 2008; Yokoseki et al., 2008).
A variety of TDP-43 mouse models have been recently devel-
oped and themost consistent behavioral features in these animals
are motor phenotypes (for review, see Tsao et al., 2012). In some
specific models, cognitive impairment was also detected (Tsai et
al., 2010; Swarup et al., 2011; Caccamo et al., 2012).Most of these
animal models are driven by pan-neuronal promoters with con-
stitutive expression, which makes it difficult to assess other as-
pectswithin the behavioral domain affected bymotor deficits and
also to circumvent the possible prenatal or early postnatal effects
of TDP-43 dysregulation (Cannon et al., 2012). To avoid these
issues and to study the contribution of TDP-43mislocalization in
disease progression, we recently developed an inducible trans-
genic (Tg) mouse that overexpresses the cytoplasmic form TDP-
43-NLS (Igaz et al., 2011). The use of the CaMKII promoter
provides selectivity of expression at the cellular level. In this case,
TDP-43-NLSwas enriched in forebrain neurons, allowing us to
study both behavioral and neuropathological phenotypes with-
out early mortality or confounds caused by the inability to per-
form cognitive or social tasks due to paralysis.
We previously reported that these animals develop time-
dependent, region-specific neuronal loss, corticospinal tract neu-
rodegeneration and a spastic motoric phenotype. In addition, we
described profound changes in cortical gene expression (Igaz et
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al., 2011). However, the specific contribution of TDP-43-NLS
expression at the behavioral level was not investigated. Here, we
sought to perform both a detailed behavioral characterization
and an assessment of neurodegeneration in these mice. More-
over, it is currently not known whether suppression of TDP-43
overexpression can arrest or reverse associated behavioral
changes. To explore the consequences of reversible TDP-43-
NLS expression, we induced the Tg at weaning and suppressed
its expression at early (0.5 month) or late (5.5 months) time
points to evaluate the relationship among behavioral abnor-
malities, regional neurodegeneration, and functional changes
in TDP-43-NLS–overexpressing neurons. Our data show
that TDP-43-NLS expression impairs multiple behavioral do-
mains affected in FTD-motor neuron disease (MND), including
motor, cognitive, and social functions. In addition, short-term
suppression of TDP-43-NLS expression reversed motoric and
cognitive (but not social) phenotypes in young mice with limited
neurodegeneration. These deficits could not be rescued by suppres-
sion in older mice displayingmore degenerated brains.
These results suggest thatTDP-43-mediatedbehavioral dysfunc-
tion is sustained by functional changes in populations of affected
neurons independently of extensive neurodegeneration and that di-
verse symptomsmight have different susceptibility to amelioration.
Materials andMethods
Transgenic mice
As described previously (Igaz et al., 2011), humanTDP-43 (hTDP-43)Tg
lines were generated by injection of linearized moPrP-tetP vector con-
taining hTDP-43-NLS cDNA into pronu-
cleus of fertilized eggs fromC57BL/6JC3HeJ
F1 matings. Monogenic tetO-TDP-NLS4
micewere bred toCamk2a-tTAmice (Mayford
et al., 1996; The Jackson Laboratory) generat-
ing nTg, tTA monogenic, single tetO-TDP-43
Tg mice (non-TDP-43 expressing control
mice), and bigenic mice expressing hTDP-43-
NLS (hereinafter referred to as tTA/NLS).
To avoid prenatal and postnatal developmen-
tal effects of Tg expression, breeding mice and
pups were treated with 0.2 mg/ml doxycycline
hyclate (Dox; sc-204734A; Santa Cruz Biotech-
nology) in drinking water unless otherwise
stated. Tg expression was activated at weaning
[postnatal day 28 (P28)] by removing Dox
fromwater andmice were analyzed at different
time points (Fig. 1A). For suppression experi-
ments, mice were treated again with 0.2 mg/ml
Dox in drinking water for the indicated times.
Genotyping from tail DNA was performed
using the following primers: TDP-forward
(TTGGTAATAGCAGAGGGGGTGGAG),
MoPrP-reverse (TCCCCCAGCCTAGACCAC
GAGAAT), Camk2a-tTA-forward (CGCTGT
GGGGCATTTTACTTTAG), and Camk2a-
tTA-reverse (CATGTCCAGATCGAAATCGTC).
Tg lines were established by crossbreeding with
C57BL/6J mice for 6–7 generations to homog-
enize genetic background. Each of the different
age groups studied for all subsequent experi-
ments contained Tg and control animals of ei-
ther sex. The experimental protocol for this
study was approved by the National Animal
Care and Use Committee of the University of
Buenos Aires.
Tg suppression protocol
Mice raised on Dox until P28 were treated
again with Dox starting at 0.5 months [1 mo-
(sup) mice] or 5.5 months [6 mo(sup) mice] after weaning to suppress
transgene expression for 2 weeks, and analyzed at 1 month or 6 months
after weaning, respectively. These mice were compared with mice in
which transgene expression was maintained until 1 month (1 mo mice)
or 6 months (6 mo mice) after weaning.
Behavioral studies
Mice (male and female) were kept on a 12 h light/dark cycle and had ad
libitum access to food and water. All behavioral tasks, except for the
Y-maze spontaneous alternation, were performed during the light phase.
All animals were allowed to habituate in the experimental room (with
attenuated light and sound) for at least 1 h before the tests. All mazes and
objects used in behavioral analysis were cleaned with ethanol 10% be-
tween test sessions.
Because all nonbigenic offspring (nontransgenic and both single
transgenic mice) exhibited similar behavioral responses, we grouped
these genotypes under the Control group to compare against the Bigenic
phenotypemice for all subsequent behavioral tests and other experimen-
tal analysis.
Open field. Open field tests were performed for assessment of general
exploratory locomotion in a novel environment. Mice were placed in a
clear Plexiglas (40 40 40 cm) arena with white floor divided into 2
zones: periphery and center (comprising 50% of the total area centered).
All activity was recorded for 20 min with a computer-linked video cam-
era mounted above the testing box. Mouse position was determined by
automatic video tracking (ANY-maze; Stoelting). Room illumination
was kept at 50 lux. Total distance and center distance traveled by themice
was analyzed. Time bin analysis (every 5 min) was used.
Rotarod. A rotarod apparatus (model 7600; Ugo Basile) was used to
measure motor coordination and balance. For the fixed speed rotarod
Figure 1. Progressive cortical and hippocampal atrophy in TDP-43-NLS transgenic mice. A, Experimental design: transgene
expressionwas activated atweaning (P28) by removingDox fromwater, followed by analysis at the indicated time points.B, Body
weight curve for non-TDP-43– expressing control (Ctrol)mice (nTg, tTA,NLS) andbigenicmice (tTA/NLS) assessed at different
times off Dox (n 10 per group). *p 0.05; ***p 0.001, two-way ANOVA/Bonferroni post hoc analysis. C, D, Cerebral cortex
and hippocampus weights for Ctrol and tTA/NLS mice at 1 and 6 months off Dox (n 5 per group). *p 0.05; **p 0.01
significantly different from Ctrol group (Student’s t test). The data are displayed asmean SEM. E, Visual perception. Percentage
of animals stopping at the edge in the visual cliff test and reaction score (mean SEM) in the visual placing response. Bigenicmice
didnot showstatistically significant impairments in visual performance (ns, nonsignificantMann–WhitneyU test; control,n12;
tTA/NLS, n 8).
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test (17 rpm), mice were given one or two practice trials and then placed
on the rotating cylinder; a 3 min cutoff per session was used. For the
accelerating rotarod test (4–40 rpm over 300 s), 4 trials per test were
performed during the test day, with a 2 min interval between trials. The
latency to fall off the rotarod was recorded for both configurations. Mice
that rotated passively were scored as fallen.
Clasping phenotype. hTDP-43-NLS Tg mice and age-matched con-
trol mice were suspended by the tail 30 cm above an open cage for 30 s,
after which they were slowly lowered toward the bottom of the cage. A
positive response was recorded for mice that clasped their limbs within
5 s of suspension while maintaining the clasping posture until lowered to
the cage.
Novel object recognition.Eachmousewas habituated to an empty Plexi-
glas arena (40 23 15 cm) for 2 consecutive days (1 10-min session the
first day and 2 5-min sessions the second day). On the third day (train-
ing), the mice were exposed to two identical objects placed at opposite
ends of the arena for 10min. Twenty-four hours later (test day), themice
were allowed to explore 1 copy of the previously presented object (famil-
iar) and a new object (novel) for 5 min. All of the sessions were recorded
using a camera mounted above the arena. Exploration was defined as
pointing the head toward an object at a distance of 2 cm from the
object, with its neck extended and vibrissae moving. As far as we could
determine, the objects had no natural relevance for the mice and they
have never been associated with a reward. Turning around and sitting on
the objects were not considered exploratory behaviors. The exploration
time represents the percentage of time that mice spend exploring the
object (familiar or novel) respect to the total exploration time (familiar
novel).
Step-through inhibitory (passive) avoidance. Inhibitory avoidance be-
havior was studied in a one-trial learning task that uses the natural pref-
erence of mice for a dark environment. The apparatus consists of a dark
Plexiglas compartment (20 20 15 cm)with a stainless-steel grid floor
and a small (5  5 cm) illuminated, elevated platform attached to its
front center. During training, each mouse was placed on the platform
and received a footshock as it stepped into the dark compartment (0.8
mA, 50 Hz, 1 s), as described previously (Boccia et al., 2004). The
retention test was performed 1.5 or 48 h later. Each mouse was placed
on the platform again and the step-through latency was recorded with
a 300 s cutoff per session. In the retention test session, the footshock
was omitted.
Y-maze spontaneous alternation test. The Y-shaped maze consisted of
three identical arms of transparent Plexiglas (43 4 12.5 cm) placed at
120° angles to each other (Belforte et al., 2010). Mice were placed at the
end of one arm facing the center and allowed to explore the maze freely
for 8 min without training, reward, or punishment. All sessions were
video recorded through a camera mounted above the maze and mouse
position was tracked using ANY-maze software. Room illumination was
kept at 30 lux. Entries into each arm were scored by an investigator and
alternation behavior was defined as a complete cycle of consecutive en-
trances into each of the 3 arms without repetition. The percentage of
spontaneous alternation was calculated as the number of alternations
divided by the possible alternations [(# alternations)/(total arm entries
2) 100]. Total entries were scored as an index of ambulatory activity in
the Y maze and mice with scores 12 were excluded. All experiments
were conducted during the initial dark phase (6:00 P.M. to 9:00 P.M.) to
maximize exploratory behavior (Belforte et al., 2010).
Social interaction test. The social interaction test was performed as
described previously (Brodkin et al., 2004; Depino et al., 2011). Briefly,
the test apparatus consisted of a black Plexiglas rectangular box (40.6
15 23 cm) with three interconnected chambers that was placed under
dim light (25 lux). The apparatus was covered with clean bedding. Before
the start of each test, one of the end chambers was randomly designated
the ‘‘nonsocial side” and the other the ‘‘social side.” During the habitu-
ation phase, 2 identical clear Plexiglas cylinders (each 7 cm in diameter,
14 cm tall) with a black plastic cover on the top were placed in the
apparatus, 1 in each end chamber. Animals (test mice) were placed in
the central chamber and allowed to explore the apparatus for 5 min. The
cylinders had multiple small holes (0.5 cm diameter) to allow for audi-
tory, visual, and olfactory investigation between test and stimulus mice.
After habituation, a stimulus mouse (a 21- to 28-d-old C57BL/6J male
mouse) was placed into the cylinder on the side that had been designated
the social side and a black plastic object was placed into de cylinder on the
nonsocial side (nonsocial stimulus). The test mouse was able to freely
explore the apparatus for 10 min (test phase). Time spent sniffing the
social and nonsocial stimuli and time spent in each chamber was mea-
sured. All sessionswere video recorded through a cameramounted above
the testing box. Clean bedding was placed on the box before the next test.
Olfactory habituation/dishabituation. The ability to recognize an at-
tractive, novel odor was assessed by the olfactory habituation/dishabitu-
ation task. As described previously (Belforte et al., 2010), eachmousewas
transferred individually into a clean cage containing fresh bedding 30
min before the test for habituation. Swabs were dipped and presented in
the following order: tap water, almond extract (1:300), banana extract
(1:300), and the bottom surface of a plastic cage containing a group of 5
male mice or 5 female mice (C57BL/6J) that had lived in the cage for 6 d.
During the test, each odor was presented 3 times consecutively for 2min.
All sessions were video recorded and cumulative time spent sniffing the
odorant in each presentation was quantified. Testing was conducted in a
30 lux illuminated room.
Self-grooming test. Self-groomingwas evaluated in a clear Plexiglas box
(26  16  14.5 cm). All activity was recorded by a video camera
mounted above the testing box for 15 min. Cumulative time spent in
grooming was measured.
Hanging wire grip test.Grip strengthwas assessed using a standardwire
cage with masking tape placed around the perimeter of the lid to prevent
the mouse from walking off the edge. The hanging wire test was per-
formed by placing the mouse on the top of the wire cage lid, the lid was
shaken lightly three times to cause the mouse to grip the wires, and then
the lidwas turned upside down. The upside-down lidwas hold at a height
	20 cm above a cage containing fresh bedding. The latency to fall off the
wire lid was quantified. A 60 s cutoff time was used.
Visual perception. Visual perception was evaluated in the visual cliff
test (Salinger et al., 2003; Belforte et al., 2010) and with the visual placing
response (Metz and Schwab, 2004). In the visual cliff test, a box with a
simulated ledge was used. The surface of the box (30 30 cm) and ledge
(60 cm high) were covered with a black-and-white checkerboard pattern
(2.5 2.5 cm) to emphasize the ledge dropoff. A piece of clear Plexiglas
spanned the ledge, resulting in the visual appearance of a cliff. The trial
began with the placement of a single mouse in the rear left corner of the
visually shallow side of the box facing away from the apparent ledge. The
behavior was scored as “positive” when the mouse stopped at the virtual
edge before attempting to cross. Visually impaired animals walk across
the Plexiglas without stopping. The percentage of animals stopping at the
edge was quantified. Each animal was tested only once. For the visual
placing response, mice were held by the tail and lowered toward a solid
surface without any contact to the vibrissae. As the head approached the
table surface, the mouse extended the paws toward the surface to reach
for a soft landing. Visually impaired mice do not see the surface coming
and do not extend the paws. The mean response was rated in 1 trial with
a scoring system as follows: 0  no observable placing response, 1  a
weak placing response, and 2 a clear placing response. For both tests,
vibrissae were removed to eliminate tactile placing responses.
Brain tissue collection
After deep anesthesia with 5% chloral hydrate (1 ml/30 g), the mice were
perfused transcardially with ice-cold PBS (0.1 M), pH 7.4, supplemented
with 10 U/ml heparin. The brains were immediately extracted and cut
sagitally into two hemispheres. One hemisphere was fixed overnight in
4% PFA and then cryoprotected in 10% and 30% sucrose in PBS for
immunofluorescence analyses. The other hemisphere was further dis-
sected into cerebral cortex, hippocampus, cerebellum, olfactory bulb,
and the rest of the tissue (subcortical structures, brainstem) and then
immediately frozen on dry ice and kept at80°C for biochemical anal-
ysis and weight measurements.
Antibodies
Antibodies used in this study were as follows: rabbit anti-TDP-43 poly-
clonal antibody raised to amino acids 394–414 (C-t TDP-43 pAb) was
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described previously (Igaz et al., 2008), a human specific mouse anti-
TDP-43 monoclonal antibody raised to amino acids 1–260 (60019-2;
Proteintech), a mouse anti-NeuN monoclonal antibody (MAB377; Mil-
lipore Bioscience Research Reagents), and an anti-GAPDH mouse
monoclonal antibody (6C5; Advanced ImmunoChemical).
Immunofluorescence
Fixed frozen hemispheres were cut (30–50 m) using a sliding freezing
microtome (SM 2010R; Leica) and stored at 20°C in cryoprotecting
solution (50% glycerol, 50% PBS) until use. After PBS (0,01 M) washes,
coronal free-floating sections were permeabilized with 1% Triton X-100
in PBS for 1 h, blocked for 1 hwith 0.3%TritonX-100 and 5%goat serum
in PBS, and incubated overnight with primary antibodies (diluted in
0.3% Triton X-100 and 3% goat serum in PBS) at 4°C with the indicated
dilutions: rabbit anti-TDP-43 1:30000, anti-hTDP-43 1:10000, and anti-
NeuN 1:1000. After washes, primary antibodies were visualized with sec-
ondary antibodies conjugated with Alexa Fluor 488 (Invitrogen) and
rhodamine (Jackson Laboratories) diluted in 0.3% Triton X-100 and 5%
goat serum in PBS for 4 h at room temperature and nuclear counterstain-
ing was done with Hoechst 33342 (2 g/ml). Sections were mounted
onto gelatin-coated slides using 30% glycerol in PBS and images were
captured with an Olympus DP71 camera attached to an Olympus IX-81
microscope or a confocal microscope (Olympus FV1000) with Fluoview
Figure2. TDP-43-NLS transgenicmicedevelopmotor abnormalities.A,B, Rotarodperformance. Bigenicmicedemonstrated an impaired ability to remainon the rod comparedwith Ctrolmice.
A, Fixed speed rotarod test (17 rpm). Mice were given 1 or 2 practice trials and then placed on the rotating cylinder; a 3 min cutoff per session was used (***p 0.001 significantly different from
Ctrol group, Student’s t test).B, Accelerated rotarod test (4– 40 rpm/5min). Four trials per testwere performedduring the test daywith a 2min interval between trials. Latency to fall off the rotarod
was recorded (*p 0.05; ***p 0.001, repeated measures two-way ANOVA/Bonferroni post hoc test). C, Hanging wire grip test. Grip strength was assessed using a standard wire cage turned
upside down. The latency to fall off the wire lid was quantified. A 60 s cutoff time was used. *p 0.05 significantly different from Ctrol group (Student’s t test). D–F, Exploratory and locomotor
activity in a novel environmentwas assessed by a 20min session in an open field chamber. TDP-43-NLS Tg animals displayed severe hyperlocomotion. Bar graphs show the total distance traveled
(D) and relative center distance (E) (***p 0.001 significantly different from Ctrol group, Student’s t test). F, Total distance traveled in time segments of 300 s (***p 0.001, repeated-measures
ANOVA/Bonferroni post hoc test).G, Percentage ofmicewith clasping phenotype at different times off Dox. Motor behavior in A–Fwas analyzed at 1month off Dox. Number of animals is indicated
in parentheses or inside plot bars. Data represent mean SEM.
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2.1 software (Olympus). All of themicrographs
show images representative of the total cell
population.
Thickness measurement and cell counting
Coronal brain sections were immunostained
for the neuronal marker NeuN. Digital images
were taken using the 4 or 40 objectives
under identical illumination and exposure set-
tings. The captured images were stored in 24-
bit TIF format and processed using ImageJ
software (version 1.46r). For thickness analysis
the cross-length of somatosensory and motor
cortex (4 images), or hippocampal dentate
gyrus granule cell layer (40 images) wasmea-
sured (n 8–10 mice per group). The quanti-
fications of NeuN-positive cortical neurons
were performed manually in a 462  348 m
area using 40 images of immunostained
brain sections of somatosensory, motor and
prefrontal cortex (layer V, bregma2.06, 1.18,
1.94 mm, respectively; Paxinos and Franklin,
2008). Two images per region of interest per
mouse were taken (n 8–10 mice per group).
SDS-PAGE and immunoblot analysis
Tissues were extracted with 10 volumes (ml/g
tissue) of RIPA buffer (0.1% SDS, 1% NP-40,
0.5% sodium deoxycholate, 5 mM EDTA, 150
mMNaCl, 50mMTris-HCl, pH 8.0) containing
protease and phosphatase inhibitor mixture
(Roche), sonicated, and centrifuged at 13 000
rpm for 20 min at 4°C. Protein concentrations
were determined using the BCA assay kit
(Pierce). Equal amounts (30 g) of samples
were subsequently resolved on 10% SDS-
PAGE gels and transferred onto PVDF mem-
branes (Immobilon-P; Millipore). Primary
antibodieswere used as follows: 1:20 000 rabbit
anti-TDP-43 and 1:2000 anti-GAPDH. Mem-
branes were probed with corresponding sec-
ondary antibodies (coupled to HRP, 1:5000;
Jackson ImmunoResearch) and visualizedwith
enhanced chemiluminescence (ECL; Pierce).
GAPDH was used as loading control. Digital
imageswere acquired using an ImageQuantRT
ECL Imager (GE Healthcare). Quantification
of band intensity was performed using ImageJ
software.
Statistical analysis
Data are expressed asmeans SEM. Statistical
analysis of behavioral tests was performed us-
ing student’s t tests when comparing only two
groups on one behavioral measure and a one-
way ANOVA followed by Newman–Keuls
multiple-comparison post hoc test when com-
paring three or more groups. For visual cliff
and visual placing tests, nonparametricMann–
Whitney U test was used. For the olfactory
habituation/dishabituation task, accelerated
rotarod and open field time segment analysis
repeated-measures ANOVA followed by Bon-
ferroni’smultiple-comparison post hoc test was
used. For clasping analysis and the inhibitory
avoidance task, nonparametric Kruskal–Wallis
one-way ANOVA followed by individualMan-
n–Whitney U test was used. Statistical analysis
of cell counting and immunoblot quantifica-
Figure 3. Cognitive deficits in TDP-43-NLS transgenic mice. A, B, Novel object recognition test. A, Training day. Mice
were exposed to two identical objects placed at opposite ends of the arena for 10 min and the time spent exploring each
object was recorded. There was no difference in object exploration of the two objects in the training phase. B, Twenty-four
hours later (test day), the mice were allowed to explore 1 copy of the previously presented object (familiar) and a new
object (novel) for 5 min. The exploration time (%) represents the percentage of time that mice spend exploring the object
(familiar or novel) respect to the total exploration time (familiar novel). tTA/NLS animals displayed no evidence of
object recognition memory (***p 0.001, one-way ANOVA/Newman–Keuls post hoc test). C, D, Y-maze spontaneous
alternation task. Mice were placed at the end of one arm facing the center and allowed to explore the maze freely for 8 min
without training, reward, or punishment. Entries into each arm were scored and alternation behavior was defined as a
complete cycle of consecutive entrances into each of the 3 arms without repetition. C, tTA/NLS mice alternated between
the arms at the chance level (**p 0.01 significantly different from Ctrol group Student’s t test). D, Total entries were
scored as an index of ambulatory activity in the Ymaze. Cognitive behavior was analyzed at 1month off Dox. E, F, Inhibitory
avoidance task. During training, each mouse received a footshock as it stepped into the dark compartment (0.8 mA, 50 Hz,
1 s). Retention test was performed 1.5 h (short-termmemory) or 48 h (long-termmemory) later. The step-through latency
was recorded; footshockwas omitted during test session. E, Bigenicmice showed intact short-termmemory comparedwith
control littermates. F, TDP-43-NLS mice had significantly lower step-through latencies 48 h after training, indicating a
deficit in long-term memory. (*p 0.05; ***p 0.001 Kruskal–Wallis one-way ANOVA followed by individual Mann–
Whitney U test). Number of animals is indicated in parentheses or inside plot bars. Data represent mean SEM.
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tions was performed using one-way ANOVA followed by Newman–
Keuls multiple-comparison post hoc tests. Prism 6 (GraphPad) or SPSS
version 17 software were used for statistical analysis and differences
were considered to be statistically significant when p  0.05.
Results
Postweaning TDP-43-NLS overexpression in forebrain
neurons leads to motor abnormalities
In this study, we used previously generated mutant TDP-43-
NLS Tg mice with a tet-off system and the CaMKII promoter
to model human TDP-43 proteinopathies (Igaz et al., 2011). Tg
expression was induced at weaning and animals were analyzed at
different times after Dox removal (Fig. 1A). The body weight
curve of these mice was indistinguishable from control litter-
mates up to 2 weeks after induction. Beyond this point, bigenic
mice were slightly (13–18%) but significantly smaller, although
the growth curve slope was similar (two-way ANOVA, F(1,182)
20.89, p 0.0001 for group; F(5,182) 84.10, p 0.0001 for time
of induction; F(5,182) 3.774, p 0.0028 for interaction; Fig. 1B).
To avoid the dilution effect of nonexpressing structures such as
cerebellum, we next analyzed the weight of two forebrain struc-
tures that highly express the Tg. Cortical and hippocampal tissue
weights from TDP-43-NLS Tg mice were significantly lower
than age-matched controls at the 6 month, but not at the 1
month, time point off of Dox (Fig. 1C,D), indicating time-
dependent atrophy of these brain areas. The physical appearance
of Tg mice revealed no visible problems (including abnormal
growth, posture, and gait) that could potentially interfere with
behavioral testing. The righting reflex was normal in Tgmice and
we found no deficits in visual function as assessed by visual plac-
ing and visual cliff tests (Fig. 1E). No evidence of muscle atrophy
was previously found as analyzed by H&E staining of forelimb
and hindlimb striated muscles (Igaz et al., 2011). All behavioral
tests were conducted at 1month after induction unless otherwise
stated.
Most transgenic mice based on TDP-43 manipulation use
pan-neuronal promoters that usually lead to rapid onset of
“swimming” gait and paralysis related to lower motor neuron
degeneration and, in some cases, eventually death (Tsao et al.,
2012). We reasoned that inducible and forebrain-enriched TDP-
43-NLS expression, sparing lower motor neuron Tg expression
and subsequent degeneration (Igaz et al., 2011), would help to
circumvent early symptoms that would make it impossible to
properly test or interpret other domains of animal behavior. Be-
cause this is a novel Tgmodel that has been previously character-
ized at the neuropathological level and at the global gene
expression pattern level, we first wanted to address the impact of
TDP-43-NLS expression onmotor function. Tgmice were sub-
jected to two variants of the rotarod test, a fixed speed version and
an accelerated version (Fig. 2A,B), and the results indicated that
they were drastically impaired in motor coordination and bal-
ance (repeated-measures ANOVA, F(1,54) 62.49, p 0.0001 for
group; F(3,54)  19.06, p  0.0001 for trial; F(3,54)  4.869, p 
0.0045 for interaction; Fig. 2B). In addition, TDP-43-NLSmice
displayed a reduction in latency to fall in a hang wire test, sug-
gesting a mild decrease in grip strength (Fig. 2C). To measure
generalmotor function and exploratory activity, we used an open
field test. TDP-43-NLS Tg animals displayed severe hyperloco-
motion and reduced relative center distance (Fig. 2D,E). More
detailed analysis of distance traveled by time bins indicated that,
during the first 5 min, locomotor activity did not differ signifi-
cantly from control mice, but was dramatically increased during
the rest of the open field test duration (repeated-measures
ANOVA, F(1,84)  36.94, p  0.0001 for group; F(3,84)  13.26,
p  0.0001 for time bin; F(3,84)  23.01, p  0.0001 for interac-
tion; Fig. 2F). Last, we performed a time course analysis of limb-
clasping reflex phenotype. Although control animals extended
their limbs normally when being suspended by their tails, by 1
month of induction, all of the Tg mice and none of the controls
displayed this altered response (Fig. 2G). Together, these data
demonstrate that TDP-43-NLS mice display early motor ab-
normalities at 1 month after Tg induction.
TDP-43-NLSmice develop cognitive deficits
CytoplasmicTDP-43 expression is a hallmark of FTLD-TDPpro-
teinopathy (Neumann et al., 2006), and both in vitro and in vivo
studies in Drosophila and mammalian models showed that
TDP-43 mislocalization might lead to TDP-43 sequestration,
toxicity, and motor impairment (Winton et al., 2008; Miguel et
al., 2011; Dayton et al., 2013). Although TDP-43 has been indi-
cated as a neuronal activity-related factor (Wang et al., 2008),
there is no clear evidence for the role of cytoplasmic TDP-43 in
memory and cognition. To determine whether restricted TDP-
Figure 4. TDP-43-NLS mice display abnormalities in social behavior. A, B, Social interac-
tion test.A, Time spent sniffing the social (P21–P28mouse) stimulus (social interaction) during
a 10 min session. 1 month off Dox bigenic mice presented a reduced social interaction time
during the session (***p 0.001 significantly different from Ctrol group, Student’s t test). B,
No difference between groupswas found in exploration time of the social chamber. C, Olfactory
habituation/dishabituation test, 1 month off Dox. Swabs were dipped in tap water, almond
extract (1:300), banana extract (1:300), and the bottom surface of a plastic cage that contained
either a group of male or female mice. A 2 min odor presentation was used. There are no
significant differences between groups (repeated-measures ANOVA/Bonferroni post hoc test).
Number of animals is indicated in parentheses or inside plot bars. The data are displayed as
mean SEM.
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43-NLS expression leads to cognitive dysfunction, we used the
novel object recognition task, which is heavily dependent on cor-
tical function and takes advantage of a rodent’s innate preference
for novel over familiar objects. During the training day, both
control and bigenicmice did not show a preference for any of two
identical objects (Fig. 3A). Twenty-four hours later (test day),
mice were presented with the same (familiar) object and a novel
object and exploration time was measured. Although control an-
imals clearly displayed the expected novel object preference,
TDP-43-NLS mice showed no preference at all, demonstrating
impaired recognition memory (one-way ANOVA, F(3,34) 
20.21, p  0.0001; Fig. 3B). We further evaluated the cognitive
performance by using other memory tests. To assess working
memory, we used the Y-maze spontaneous alternation test,
which depends on prefrontal cortex function and also on the
hippocampus due to the spatial nature of the task. The Y-maze
test relies on the animal’s preference to investigate a new arm of
the maze rather than returning to a previously visited arm (Bel-
forte et al., 2010). We measured the percentage of spontaneous
alternation and found that, whereas control mice avoided the
previously visited arms, Tg mice alternated at chance (50%)
level, indicating impaired working memory (Fig. 3C). Impor-
tantly, the total number of arm entries was similar between
groups (Fig. 3D).
To evaluate associative learning, we performed the inhibitory
avoidance task, another cognitive test that has the additional ad-
vantage of being an associative, fear-motivated learning para-
digm. During the training session, latency to step through a dark
compartment was not different between 2-month off Dox con-
trol and Tg mice (Fig. 3E,F). Mice were given a footshock upon
entrance to the dark chamber and tested 48 h later for inhibitory
avoidance memory. Although control mice showed very high
latency to enter the dark compartment (i.e., retained thememory
for the aversive event), bigenicmice had significantly lower laten-
cies, indicating a deficit in long-term memory for this task (Fig.
3F). Importantly, a group of mice tested 1.5 h after training
Figure 5. Assessment ofmotor, visual, social, and cognitive behavior in control and bigenicmice raised continuously on Dox until 1month after weaning.A, Accelerated rotarod test.B, Hanging
wire grip test. C, Limb-claspingmotor phenotype and visual placing response test.D–F, Exploratory and locomotor activity in the open field test.D, Total distance traveled in the open field chamber.
E, Relative center distance during the open field session. F, Open field time bin analysis.G,H, Social interaction test.G, Time spent sniffing the social stimulus during a 10min session.H, Exploration
time of the social chamber. I, J, Y-maze alternation task. I, Percentage of spontaneous alternation during an 8min session. J, Total entries scored. No differences between control and bigenic groups
were found in the behavioral analysis (A and F: repeated-measures ANOVA, F(1,18) 1.177, p 0.3196 for group in A and F(1,21) 0.2129, p 0.6585 for group in F; B, D, E, G–J: p
 0.05,
Student’s t test; C: p
 0.05, Mann–Whitney test). Data represent mean SEM (Ctrol, n 5; tTA/NLS, n 4).
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Figure6. TDP-43-NLS suppression reversesmotoric phenotypes in young transgenicmice.A, Experimental design.Mice raised onDoxuntil P28were treated againwithDox at 0.5months after
weaning to suppress transgene expression during 2 weeks [1 mo(sup) mice] and analyzed 1 month after weaning. These mice were compared with mice in which transgene expression was
maintaineduntil 1month afterweaning (1momice, Ctrol and tTA/NLS).B, Double immunofluorescence for total TDP-43andhTDP-43 in coronal brain sections from1mo (Ctrol and tTA/NLS) and
1mo(sup)mice. Scale bar, 250m; inset, 20m. C, Immunoblot of total TDP-43 (hmTDP-43) in cortical RIPA extracts. GAPDHwas used as a loading control.D, Quantification of the immunoblot
shown in C (***p 0.001, one-way ANOVA/Newman–Keuls post hoc test, n 4 per group). E–K, Assessment of general motor behavior was performed in 0.5 mo, 1 mo, and 1mo(sup) mice. E,
Fixed speed rotarod test. F, G, Accelerated rotarod test.H, Total distance traveled in the open field chamber. I, Relative center distance during the open field session. J, Open field time bin analysis.
K, Abnormal limb-clasping motor phenotype. 0.5 mo bigenic mice already displayed an altered motor behavior compared with Ctrol littermates (E, H, I, left; F ). Remarkably, (Figure legend continues.)
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showedno significant decrease in latency comparedwith controls
(Fig. 3E), demonstrating that TDP-43-NLS mice can acquire
the task and have intact short-term memory but cannot consoli-
date it into a long-lasting memory. These results indicate that
neuronal TDP-43-NLS overexpression in forebrain regions im-
paired cognitive function as assessed by multiple behavioral
tasks.
Social dysfunction in TDP-43-NLS mice
Although cognitive and motor symptoms occur to different de-
grees within the FTD spectrum, patients affected with this disease
display other types of behavioral deficits. A core feature of FTD is
repetitive behavior, which is useful for the revised diagnostic cri-
teria and is present inmost FTDpatients. Inmice, this commonly
takes the form of excessive grooming and other stereotypies. We
studied the occurrence of spontaneous grooming in control and
TDP-43-NLS bigenic mice and found no significant differences
in total grooming time (71.37  12.53 s vs 55.95  10.01 s for
control and TDP-43-NLSmice, respectively; t(18) 0.9617, p
0.3489).
One of the earliest and most prominent symptoms of FTD is
social dysfunction, which can be expressed as diminished social
interest.We tested the social behavior of TDP-43-NLSmice at 1
month after induction using a 3-chamber social interaction test
(Moy et al., 2004). As expected, control mice spent more time
interacting with the other mouse (social stimulus) than with the
inanimate object (nonsocial stimulus). However, TDP-43-NLS
expressing mice showed drastically reduced sociability, because
the preference for the social stimulus was significantly lower than
in control animals (Fig. 4A). Exploration time in the social side
was similar between groups, indicating that this decrease in social
interaction time is not due to increased anxiety-like behavior or
perception of the stimulus as aversive (Fig. 4B). Because the per-
formance in this test depends critically in proper olfaction and
the CaMKII promoter drives Tg expression in the olfactory
bulb, we also tested olfactory performance using a habituation/dis-
habituation test. Bigenicmice did not display significant differences
in performance for both nonsocial and social odoriferous stimuli,
suggesting intact olfactory function (repeated-measures ANOVA,
F(1,112)  0.02245, p  0.8846 for group; F(14,112)  14.77, p 
0.0001 for odorant; Fig. 4C). These results show that TDP-43-NLS
mice exhibit an altered social behavior.
A potential contributor for the behavioral abnormalities ob-
served inTDP-43-NLSmice is a possible insertional effect of the
Tg in the genome. To rule out this possibility, we performed a
variety of tests encompassing all the previously assessed behav-
ioral domains in bigenic animals continuously treated with Dox
throughout the experiment. Importantly, these animals with 2
months of constant suppression of TDP-43-NLS expression
showed responses indistinguishable from control mice in all pa-
rameters evaluated (Fig. 5).
Suppression of TDP-43-NLS Tg reverses motor deficits in
young mice
Currently, there are no effective disease-modifying therapies for
TDP-43 proteinopathies. It is basically unknown whether target-
ing TDP-43 can inhibit neurodegeneration and reverse behav-
ioral abnormalities. Having established that TDP-43-NLSmice
exhibit a neurological phenotype, we were interested in deter-
mining whether turning off the TDP-43 Tg would ameliorate the
symptoms in phenotypic mice. First, we defined a time point of
interest (1month after induction) and then decided to treat mice
with Dox 2 weeks before that point to suppress TDP-43-NLS
expression (Fig. 6A).We chose 2 weeks off Dox as a starting point
because we previously demonstrated global changes in cortical
gene expression seemingly without overt general neurodegenera-
tion at that specific postinduction time. In addition, TDP-43-
NLS expression is almost maximal starting at 1 week after
induction (Igaz et al., 2011). Both control and bigenic mice were
separated into two subgroups (with andwithout Dox treatment),
butwe decided to poolDox-treated and untreated control groups
after the analysis because they were indistinguishable in all pa-
rameters evaluated. Bigenic mice with and without Dox treat-
ment were analyzed separately. To assess proper regulation of Tg
expression, we performed double immunofluorescence studies
using a polyclonal antibody (referred as total TDP-43) that reacts
to both endogenous (mouse) and Tg (human) forms of TDP-43
and a monoclonal antibody that only recognizes the human iso-
form of the TDP-43 protein (in this case, TDP-43-NLS),
termed hTDP-43. Representative micrographs show that mice
from the 1mo(sup) group are almost completely devoided of
hTDP-43 immunoreactivity (Fig. 6B). Immunoblot analysis of
cortical RIPA fractions extracted from the other hemisphere
of the same experimentalmice (Fig. 6C) confirmedTg expression
reduction to basal levels in the suppressed group (one-way
ANOVA, F(2,9) 105.5, p 0.0001; Fig. 6D), and similar levels to
those previously reported in bigenic mice 1 month after induc-
tion (Igaz et al., 2011).
Although we established that bigenic mice display a motor
phenotype 1 month after induction (Fig. 2), we wanted to deter-
mine whether the behavioral abnormalities were already present
at the starting time point of suppression (0.5 month induction).
In this way, we could differentiate between prevention and rever-
sion of the phenotype by Tg suppression. Behavioral analysis at
0.5 months after induction revealed significant deficits in bigenic
mice for both the fixed (Fig. 6E, left) and accelerated rotarod tests
(repeated-measures ANOVA, F(1,48)  29.70, p  0.0001 for
group; F(3,48)  9.931, p  0.0001 for trial; F(3,48)  2.110, p 
0.1113 for interaction; Fig. 6F). Remarkably, ANOVA followed
by post hoc analysis showed that animals from the 1mo(sup)
group recovered, displaying nonsignificant differences compared
with control mice in the fixed speed test (one-way ANOVA,
F(2,36)  22.96, p  0.0001; Fig. 6E, right). In the accelerated
rotarod test, suppressed animals displayed a significant reversion
of the phenotype, although they did not reach the performance
level of controls (repeated-measures ANOVA, F(2,117)  31.79,
p 0.0001 for group; F(3,117) 24.86, p 0.0001 for trial; F(6,117)
1.461, p 0.1977 for interaction; Fig. 6G). When we performed a
similar analysis in the open field test, the results showed that Tg
suppression fully reversed an establishedmotor phenotype (one-
way ANOVA, F(2,67) 46.87, p 0.0001 and F(2,68) 51.23, p
0.0001 for Fig. 6H, right, Fig. 6I, right, respectively; repeated-
measuresANOVA,F(2,201)46.29,p0.0001 for group; F(3,201)
29.41, p  0.0001 for time bin; F(6,201)  28.02, p  0.0001 for
interaction; Fig. 6J). Last, we evaluated the clasping reflex and
4
(Figure legend continued.) 1mo(sup) mice recover frommotoric abnormalities (E,H, I, right; G,
J,K). (E,H, I, left: ***p 0.001 significantly different from Ctrol group, Student’s t test; E,H, I,
right: ***p 0.001, one-wayANOVA/Newman–Keuls post hoc test; F,G **p 0.007; ***p
0.001 repeated-measures ANOVA/Bonferroni post hoc analysis; J: ***p 0.001 significantly
different from 1mo Ctrol and 1 mo(sup) (repeated measures ANOVA/Bonferroni post hoc anal-
ysis). K, 1mo tTA/NLS differs significantly from 1mo Ctrol and 1mo(sup) tTA/NLS (‡p
0.001, Kruskal–Wallis one-wayANOVA/Mann–WhitneyU test).Numberof animals is indicated
in parentheses or inside plot bars. Data represent mean SEM.
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also observed a significant recovery of performance in suppressed
animals (Kruskal–Wallis statistic 63.14, p 0.0001; Fig. 6K).
Together, these data demonstrate that short-term suppression of
Tg expression can fully recover motoric abnormalities in young
TDP-43-NLS mice.
Short-term TDP-43-NLS expression leads to mild
neurodegeneration in young mice
An important question that arises from the behavioral experi-
ments in suppressed mice is whether those deficits strongly cor-
relate with neurodegeneration in regions relevant for the affected
tasks or if they are caused by changes in neuronal function in
TDP-43-NLS–expressing cells without major neuronal loss in
implicated circuits. To address this issue, we evaluated gross at-
rophy and neuronal loss in selected brain areas by immunostain-
ing with NeuN, a marker of mature neurons. Total tissue weight
suggested that, at 1 month after induction, there was no major
neuronal loss (Fig. 1C,D), but measurements of overall weight of
a brain structure cannot discriminate between neurodegenera-
tion in different subfields or regions. We performed a series of
thicknessmeasurements of somatosensory (SSC) andmotor cor-
tex (MC), as well as of the granule cell layer (GCL) of hippocam-
pal dentate gyrus (DG). We confirmed and expanded our
observation that granule cells in the DG were very susceptible to
TDP-43-NLS–associated degeneration in these mice (Fig. 7A)
(Igaz et al., 2011). GCL thickness was significantly reduced in
tTA/NLSmice compared with controlmice (one-way ANOVA,
F(2,22)  9.064, p  0.0013; Fig. 7A). Interestingly, 1mo(sup)
mice showed a significant increase with respect to the 1mo group,
but also a significant decrease with respect to control mice, sug-
gesting an intermediate phenotype and a very rapid onset of gran-
ule cell loss. Cortical thickness fromSSCandMC inboth 1month
off Dox and 1mo(sup) mice was not significantly different from
the control group (Fig. 7B,C).
To determine whether there were signs of incipient neuronal
loss in cortical regions, we examined them in greater detail by
counting the number of NeuN-positive cells. Given that brains
from both FTD and TDP-43murinemodels (including TDP-43-
NLS mice) display increased ubiquitinated aggregates, reactive
gliosis, and neurodegeneration in layer 5 (Seeley, 2008; Wegor-
zewska et al., 2009; Igaz et al., 2011), we focused our analysis on
this layer. We detected no significant changes in SSC or MC
neuronal numbers at 0.5months after induction (Fig. 7D,E, left).
At 1 month after induction, there was a mild but significant de-
crease in SSC neuronal counts, similar to those presented by 1mo
tTA/NLS(sup) bigenic animals (one-way ANOVA, F(2,13) 
9.069, p  0.00343; Fig. 7D). MC and prefrontal cortex (PFC)
neuronal numbers from the 1mo group also showed a significant
Figure 7. Mild neurodegeneration in young TDP-43-NLS transgenic mice. A–C, Immunofluorescence staining for the neuronal marker NeuN in coronal brain sections (top) and thickness
measurements (bottom) from DG granule cell layer (A), SSC (B), andMC (C) from 1mo Ctrol, tTA/NLS, and tTA/NLS(sup)mice. DG thickness was significantly reduced in tTA/NLSwith respect
to Ctrol mice. Scale bars: A, 50m; B and C, 250m. D–F, Quantification of NeuN-positive cells in cortical regions (layer 5). SSC (D), MC (E), and PFC (F). 1 mo tTA/NLSmice showed significant
neuronal loss in the SSC,MC, andmPFC regions. Data are presented as total NeuN-positive cells per area (*p0.05; **p0.01; ***p0.001 one-wayANOVA/Newman–Keulspost hoc test). Data
represent mean SEM (n 8–10 per group).
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decrease in bigenic animals relative to controls; this was not ob-
served in the 1mo(sup) mice (one-way ANOVA, F(2,25) 4.438,
p  0.0224; Fig. 7E, right, F(2,18)  3.566, p  0.0496; Fig. 7F).
The variable response in neuronal loss observed in the suppressed
group indicates that different regions are differentially suscepti-
ble to the manipulation.
NeuN relocalization to the cytoplasm can be used as an indi-
cator of neuronal injury (Robertson et al., 2006; Aviles-Reyes et
al., 2010). Although control mice display basically no cortical
neurons with alteredNeuN localization, 1month off Dox bigenic
mice showed an increase in injured SSC neurons, which was re-
versed with Tg suppression. A similar trend was observed in MC
and PFC, although less markedly (data not shown). These data
suggest that Dox treatment halts neurodegeneration, increas-
ing the proportion of surviving and decreasing the number of
injured neurons and thus incrementing the number of func-
tionally active units in the remaining circuits necessary for the
affected behaviors.
Suppression of TDP-43-NLS expression in youngmice
ameliorates cognitive but not social abnormalities
Because different behavioral domains might be differentially af-
fected by arresting Tg expression, we also investigated whether
Dox treatment could reverse other phenotypic changes in addi-
tion to motor performance. We assessed whether cognitive dys-
function was already detectable at the beginning of the
suppression (0.5 months off Dox) using the Y-maze test and
found that bigenic mice alternate at chance levels (Fig. 8A, left).
Remarkably, Dox treatment was able to rescue spatial working
memory (one-way ANOVA, F(2,42) 7.894, p 0.0012; Fig. 8A,
right). Total entry number was similar in all groups (one-way
ANOVA, F(2,42)  1.787, p  0.3304; Fig. 8B, right). When we
analyzed the social behavior, deficits were already present at 0.5
months off Dox, although to a lesser extent than 1-month-
induced mice (Fig. 8C, left). Tg suppression did not cause any
improvement in social interaction (one-way ANOVA, F(2,35) 
19.84, p  0.0001; Fig. 8C, right) and, importantly, exploration
time was equivalent among experimental groups (one-way
ANOVA, F(2,35)  0.4996, p  0.6118; Fig. 8D). These results
indicate that most behavioral phenotypes develop quite rapidly
after Tg induction; however, neural circuits subserving diverse
behavioral domains are differentially affected by TDP-43-NLS
at this early time point.
Persistence of motor deficits in 6 months off Doxmice with
TDP-43-NLS suppression
In many neurodegenerative disease models, it is generally as-
sumed that once the behavioral abnormalities are established, the
concurrent and progressive neurodegeneration that takes place is
increasingly responsible for the associated behavioral pheno-
types.Given that ourmodel has a rapid onset of these deficitswith
relativelymild neuronal loss, we wanted to study the potential for
reversibility in a domain that was impaired at early time points
after Tg induction but was fully reversed by suppressing its ex-
pression. We first established a protocol for short-term suppres-
sion in older mice with 5.5 months of Tg expression (Fig. 9A). As
shown for 1mo(sup) animals (Fig. 6B–D), mice with long-term
Tg expression were effectively repressed by 2 weeks of Dox treat-
ment, as evidenced by double immunofluorescence (Fig. 9B) and
immunoblot studies (Fig. 9C) in 6mo(sup) mice (one-way
ANOVA, F(2,8)  18.19, p  0.0011; Fig. 9D). Because motor
performance was a behavioral parameter that recovered after Tg
Figure 8. Reversal of cognitive but not social abnormalities in young bigenic mice after suppression of TDP-43-NLS expression. Assessment of cognitive and social behavior was performed in
0.5 mo, 1mo (Ctrol and tTA/NLS), and 1 mo tTA/NLS(sup) mice. A, B, Y-maze alternation task. A, Percentage of spontaneous alternation during an 8 min session. B, Total entries scored. C, D,
Social interaction test.C, Time spent sniffing the social stimulusduringa10min session.D, Exploration timeof the social chamber. Cognitive and social interactiondysfunctionwasalreadydetectable
at 0.5mo off Dox (A, C, left; **p 0.01,***p 0.001 significantly different from Ctrol group, Student’s t test). hTDP-43-NLS suppressionwas able to rescue cognitive abnormalities, but did not
cause any improvement in social interaction (A,C, right; *p0.05; **p0.01; ***p0.001, one-wayANOVA/Newman–Keulspost hoc test). Number of animals is indicated inside plot bars. Data
represent mean SEM.
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Figure 9. Transgene suppression in older (6months off Dox)mice does not reversemotor abnormalities.A, Experimental design. Mice raised on Dox until P28were treated againwith Dox at 5.5
months after weaning to suppress transgene expression during 2 weeks (6mo(sup) mice) and analyzed at 6 months after weaning. These mice were compared with mice in which transgene
expressionwasmaintained until 6months afterweaning (6momice, Ctrol, and tTA/NLS).B, Double immunofluorescence for total TDP-43 (green) andhTDP-43 (red) in coronal brain sections from
6mo (Ctrol and tTA/NLS) and 6mo(sup) mice. Scale bar, 250m; inset, 20m. C, Immunoblot of total TDP-43 (hmTDP-43) in cortical RIPA extracts. GAPDH was used as a loading control. D,
Quantification of the immunoblot shown in C (**p 0.01, one-way ANOVA/Newman–Keuls post hoc test, n 3 per group). E–G, Motor behavior analysis was performed in 6mo and 6mo(sup)
mice. E, Accelerated rotarod test. F, Percentage of mice with abnormal limb-clasping motor phenotype. G, Total distance traveled (left) and relative center distance (right) during an open field
session. As expected, tTA/NLS 6momice presentedmotor abnormalities in all the tests performed; however, hTDP-43-NLS suppressionwas unable to rescue these behavioral abnormalities (E;
**p  0.001; ***p  0.001 significantly different; ns, nonsignificant, p  0.111, repeated-measures ANOVA/Bonferroni post hoc analysis; G; ***p  0.001, (Figure legend continues.)
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suppression in young mice, we assessed the animals in the accel-
erated rotarod test. As expected, 6 months off Dox bigenic mice
performed poorly on this task but, contrary to what happened
when younger mice were suppressed, Dox treatment failed to
rescue their performance, because comparison of 6mo(sup) ver-
sus 6mo mice reveals nonsignificant differences between these
two groups (repeated-measures ANOVA, F(2,44)  25.90, p 
0.0001 for group; F(3,44)  21.98, p  0.0001 for trial; F(6,44) 
0.6665, p  0.6768 for interaction; Fig. 9E). Similarly, full pen-
etrance of the clasping abnormalities was not modified by Tg
suppression (Kruskal-Wallis statistic  63.00, p  0.0001; Fig.
9F ). In the open field test, hyperlocomotion and decreased
relative center distance were also manifest and insensitive to
Dox treatment (one-way ANOVA, F(2,41) 12.24, p 0.0001
for total distance traveled and F(2,41)  23.65, p  0.0001 for
relative center distance; Fig. 9G). Last, we assessed the degree
of atrophy in relevant brain areas and found robust and wide-
spread neuronal loss in SSC, MC, and DG, as indicated by
decreased cortical and GCL thickness (one-way ANOVA, F(2,9) 
10.03, p 0.0051 for SSC, F(2,9) 52.37, p 0.0001 for MC and
F(2,9) 185.3, p 0.0001 for DG; Fig. 9H–J). These data indicate
that, once extensive neurodegeneration occurs, functional
changes in the remaining neurons might not be sufficient to re-
cover complex behaviors that require those affected networks.
Discussion
In this study, we performed a thorough behavioral assessment of
TDP-43-NLS mice and established that progressive neurode-
generation occurs in several affected brain areas.We took advan-
tage of this inducible model to address the question of whether a
neurological phenotype, once present in the mice, could be re-
versible after turning off Tg expression. In addition, the cell-
population- and time-restricted expression of the Tg allowed us
to dissect the contribution of forebrain neurons without the in-
volvement and confounds of lowermotor neuron expression and
subsequent degeneration.
The major findings of our study are as follows. First, we
showed that TDP-43-NLS mice exhibited behavioral deficits
related to TDP-43 proteinopathies, including motor impair-
ment, reduced social interaction, and cognitive deficits (Figs.
2,3,4). Second, we found that after TDP-43 returned to normal
levels, some (Figs. 6, 8) but not all (Fig. 8) behavioral deficits were
ameliorated in young bigenic mice. The reversibility of the defi-
cits after turning off TDP-43 overexpression suggests that the
phenotypes in TDP-43-NLS mice were mainly due to the Tg
expression, not to insertional effects of the Tg into the genome.
Third, our studies indicate that regional and time-dependent
neurodegeneration occurs in these Tg mice, including areas rel-
evant for the affected behavioral tasks (Figs. 7, 9). Fourth, we
show that the same short-term suppression of Tg expression in
older mice displaying more extensive neurodegeneration is not
sufficient to improve behavioral performance (Fig. 9), indicating
that a certain number of neurons must be preserved to compen-
sate for the alterations elicited by TDP-43-NLS overexpression.
These results suggest that TDP-43-mediated behavioral dys-
function is sustained by functional changes in populations of
affected neurons independently of extensive neurodegenera-
tion and that diverse symptoms might have different suscep-
tibility to amelioration.
It has been reported previously that overexpression of diverse
TDP-43 species using viral or transgenic approaches has an im-
pact in different (mostly motor) behavioral measures in mouse,
rat, and primate animal models (Tsai et al., 2010; Zhou et al.,
2010; Igaz et al., 2011; Swarup et al., 2011; Caccamo et al., 2012;
Uchida et al., 2012; Dayton et al., 2013). The impairment of mo-
tor, cognitive, and social function observed in our mouse model
correlates poorly with TDP-43 aggregation and cleavage because
the occurrence of pathological TDP-43-positive accumulations
and proteolytic fragments is minimal or nonexistent in these
mice (Igaz et al., 2011). In addition, a full-blown behavioral phe-
notype is rapidly established after Tg induction in young mice in
the absence ofmassive neurodegeneration.Moreover,motor and
cognitive functions are remarkably ameliorated after Tg suppres-
sion. These findings underscore the notion that some behavioral
deficits in young mice are more likely the result of abnormal
neuronal function of TDP-43-NLS–expressing cells, which are
still alive and participate in the relevant circuits, rather than being
due to the mere loss of a specific population of neurons. Because
continuous Tg expression for 6 months led to overt neurodegen-
eration, as indicated by gross atrophy of cortical and granule cell
layers, one might speculate that a critical threshold of neuronal
loss has been reached beyond which no renormalization of neu-
ronal function can be reached by Tg suppression. However, it
must be pointed out that although the time frame thatwe used for
suppression might be sufficient to reverse some deficits at
younger age, longer suppression periods might be required for
recovery of behavioral function in animals exposed to extended
Tg expression.
A novel cytoplasmic role for TDP-43 has been described
recently (Alami et al., 2014). TDP-43 functions in the cyto-
plasm to transport mRNA granules selectively in a predomi-
nantly anterograde manner and alterations in this process
(either by familial mutations or unknown factors) might have
direct consequences that contribute to selective degeneration
of cellular subtypes, specifically neurons. In addition, it is
becoming increasingly clear that the FTD-ALS spectrum is not
only a disorder of proteostasis, but also of RNA homeostasis
(Ling et al., 2013; Ramaswami et al., 2013). Our animal model
might be useful to address in vivo some of these issues, because
reversible overexpression of a cytoplasmic form of TDP-43
might modify the assembly, distribution, composition, and
transport of these mRNA granules, with implications for neu-
ronal function and survival.
Cognitive and social dysfunction has been reported in FTD
rodent models (Roberson, 2012) mainly in tau-based mice, but
also in different valosin-containing protein (VCP), progranulin
(PRGN), and TDP-43 transgenic animals. Neuronal overexpres-
sion of a disease-associated VCP mutation led to age-dependent
ubiquitin and TDP-43 accumulation and decline in cognitive
function, including deficits in spatial memory, object recogni-
tion, and fear conditioning (Rodriguez-Ortiz et al., 2013).
PRGN-deficient mice, which model PGRN haploinsufficiency-
related FTD, display early changes in social behavior and late-
stage impairment in spatial learning and memory as assessed in
the Morris water maze. These deficits were associated with neu-
ropathological changes such as accumulation of ubiquitin and
4
(Figure legend continued.) one-way ANOVA/Newman–Keuls post hoc test; F, ‡p 0.001 sig-
nificantly different from 6mo Ctrol, Kruskal–Wallis one-way ANOVA followed by individual
Mann–Whitney U test). Number of animals is indicated in parentheses or inside plot bars. Data
represent mean SEM. H–J, Immunofluorescence staining for the neuronal marker NeuN in
coronal brain sections (top) and thicknessmeasurements (bottom) fromSSC (H),MC (I), andDG
(J) granule cell layer from 6mo (Ctrol and tTA/NLS) and 6mo(sup) mice. *p 0.05; **p
0.01; ***p 0.001, one-way ANOVA/Newman–Keuls post hoc test. Scale bars: H and I, 250
m; J, 50m. Data represent mean SEM (n 4 per group).
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cytosolic phosphorylated TDP-43 in the hippocampus (Yin et al.,
2010). Social and cognitive abnormalities were also recapitulated
in other PRGN-deficient mice (Ghoshal et al., 2012; Petkau et al.,
2012). TDP-43 transgenic and viral-based models also showed
different degrees of cognitive impairment, including those
overexpressing TDP-43 C-terminal fragments, disease-associated
mutations, or even the wild-type protein (Tsai et al., 2010; Swarup
et al., 2011; Caccamo et al., 2012; Dayton et al., 2012; Dayton et
al., 2013). Remarkably, social dysfunction has not been described
previously in TDP-43–basedmodels of disease, underscoring the
fact that our Tg mice might provide a platform for studying this
rapidly established and nonreversible phenotype.
Although finding behavioral assays to properly characterize
FTD mouse models might seem challenging, there are several
features that are amenable to behavioral analysis in rodents. For
example, social dysfunction is an aspect of FTD that can be ex-
amined in mice and social tests have proven to be useful in dis-
orders with prominent social deficits such as autism (Crawley,
2007). Another symptom that can be assessed is repetitive behav-
ior, which is characteristic of FTD and can become disabling
(Mendez et al., 2005). In this study, we analyzed both of these
features to understandmore comprehensively the behavioral ab-
normalities in ourmice. Recent reports describe striatal degener-
ation in FTD patients (Halabi et al., 2013), a subcortical structure
relevant for social and emotional processing (Ba´ez-Mendoza
and Schultz, 2013; Nieh et al., 2013). In our mice, the
CaMKII promoter drives Tg expression in striatal neurons,
potentially contributing to some of the deficits described here.
Impaired fear processing can also be assessed in Tg mouse
models using fear conditioning and other aversive paradigms
to evaluate amygdalar dysfunction, which is also associated
with FTD (Hoefer et al., 2008). TDP-43-NLS mice display
abnormal fear-related behavior as assessed by inhibitory
avoidance, a hippocampal and amygdala-dependent aversive
task (Cammarota et al., 2008).
One of the limitations of our model is originated by the very
same feature that provides specificity of Tg expression. Although
“cleaner” than pan-neuronal promoters, the forebrain-enriched
pattern of neuronal expression provided by the CaMKII pro-
moter also introduces a bias in the behavioral effects provoked by
TDP-43-NLS expression. It would certainly be informative to
compare the toxicity and functional changes elicited by ex-
pressing this Tg in a different cell population (i.e., spinal cord
motor neurons). Although some of the transgenic tools to
undertake these studies are currently available, these models
can provide little or limited information due to early lethality
or pleiotropic effects that might obscure the interpretation of
behavioral data.
The remarkably rapid effect of postweaning Tg expression on
several behavioral domains prompted us to propose that normal
TDP-43 roles are being disrupted by TDP-43-NLS and that this
leads to altered functionality of the affected neurons. Although
TDP-43-NLS expression has been shown to be primarily cyto-
plasmic both in vitro and in vivo by other laboratories and our
previous work (Winton et al., 2008; Igaz et al., 2011;Miguel et al.,
2011; Dayton et al., 2013), it cannot be excluded that residual
transgene expression in the nucleus may contribute to the phe-
notype observed here. Several reports show that manipulation of
TDP-43 levels or subcellular localization have a profound impact
in mRNA/microRNA levels andmRNA splicing patterns, among
other TDP-43 downstream effects (Buratti et al., 2010; Igaz et al.,
2011; Polymenidou et al., 2011; Tollervey et al., 2011; Kawahara
and Mieda-Sato, 2012; Zhang et al., 2013). Moreover, because
short-term Tg suppression reverses some behavioral deficits and
halts neurodegeneration in affected brain regions, we interpret
this tomean that themajority of TDP-43-NLS–expressing neu-
rons recover and are capable of properly sustaining the behaviors
we tested when they belong to circuits or structures that have not
suffered from major neurodegeneration (as demonstrated in
young mice). This would not be the case for animals that present
severe neuronal death (i.e., 6 months off Dox) and cannot revert
to a normal phenotype after suppression. We consider this to be
a relevant hypothesis that can be addressed by in vitro and in vivo
electrophysiological methods applied to our animal model. Fur-
ther analysis will be required to determine whether basal synaptic
transmission and synaptic plasticity is altered in TDP-43-NLS
mice.
In sum, we propose that inducible TDP-43-NLS mice con-
stitute a novel and useful model of TDP-43 proteinopathies such
as FTLD-TDP and FTLD-MND and might provide a versatile
platform to perform pharmacological, electrophysiological, and
behavioral studies to better understand the pathophysiology of
these devastating and incurable diseases.
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